Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children

Archives of Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 8, 2003, Pages 841-846

  Akst, Lee M ^b   Lee, Walter ^b   Discolo, Christopher ^b   Knott, Daniel ^b   Younes, Abbas ^b   Koltai, Peter J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ALPHA INTERFERON; CIDOFOVIR;

ADOLESCENT; ARTICLE; CARBON DIOXIDE LASER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HUMAN; LARYNX PAPILLOMATOSIS; MALE; MICROLARYNGOSCOPY; PROSPECTIVE STUDY; RESPIRATORY TRACT TUMOR; TUMOR RECURRENCE; WART VIRUS;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYTOSINE; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LARYNGOSCOPY; LASER SURGERY; MALE; ORGANOPHOSPHORUS COMPOUNDS; PAPILLOMA; PHOSPHONIC ACIDS; PROSPECTIVE STUDIES; RESPIRATORY TRACT NEOPLASMS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0042090610     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.129.8.841     Document Type: Article

References (13)

1. Derkay CS. Task force on recurrent respiratory papillomas: a preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121:1386-1391.
2. Bauman NM, Smith RS. Recurrent respiratory papillomatosis. PediatrClin North Am. 1996;43:1385-1401.
3. Pransky SM, Kang DR. Tumors of the larynx, trachea, and bronchi. In: Bluestone CD, Stool SE, Kenna MA, eds. Pediatric Otolaryngology. Vol 2. Philadelphia, Pa: WB Saunders Co; 1996:1402-1414.
4. Avidano MA, Singleton GT. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg. 1995;112:197-202.
5. Pransky SM, Magit AE, Kearns DB, Kang DR, Duncan NO. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg. 1999;125:1143-1148.
6. Pransky SM, Brewster DF, Magit AE, Kearns DB. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2000;126:1239-1243.
7. Baker GE, Tyring SK. Therapeutic approaches to papillomavirus infections. Dermatol Clin. 1997;15:331-340.
8. Zabawski EJ, Cockerell CJ. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects. J Am Acad Dermatol. 1998;39:741-745.
9. Van Cutsem E, Snoeck R, Van Ranst M, et al. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3hydroxy-2-phosphonylmethoxypropyl)cytosine. J Med Virol. 1995;45:230-235.
10. Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol. 1998;54:219-225.
11. Dancey DR, Chamberlain DW, Krajden M, Palefsky J, Alberti PW, Downey GP. Successful treatment of juvenile laryngeal-papillomatosis-related multicystic lung disease with cidofovir. Chest. 2000;118:1210-1214.
12. Derkay CS, Malis DJ, Zalzal G, Wiatrik BJ, Kashima HK, Coltrera MD. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope. 1998;108:935-937.
13. Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol. 1999;9:379-386.